← Leaderboards
Sandra H Gianturco
University Of Alabama At Birmingham
$2,078,212
Attributed
$2,078,212
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,078,212 · 2
By mechanism
R01$2,048,683 · 1
M01$29,529 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Jere P Segrest$11,891,952
- Nassrin Dashti$4,628,942
- G M Anantharamaiah$8,833,772
- Michael A Miller$3,110,395
- C Roger White$4,758,827
Others in their field
Top investigators on “Blood Lipoprotein Metabolism”
- Stephen G Young · J. David Gladstone Institutes$29,722,890
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$27,554,408
- Daniel James Rader · University Of Pennsylvania$27,468,817
- Ira Jay Goldberg · New York University School Of Medicine$18,670,223
- Frank M Sacks · Brigham And Women'S Hospital$17,260,722
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$15,769,725
Research focus
Blood Lipoprotein MetabolismTriglyceridesMonocyteGenetically Modified AnimalsClinical ResearchHuman SubjectApolipoprotein BImmunocytochemistryMacrophageLaboratory MouseReceptor BindingSds Polyacrylamide Gel ElectrophoresisAtherosclerosisCoronary DisorderApolipoprotein EBlood LipoproteinBlood Lipoprotein BiosynthesisCho CellsDisease /Disorder ModelEmbryonic Stem CellGene ExpressionGene MutationGenetic RecombinationHuman Tissue
Grant awards (8)
Distinct Human Macrophage Receptor for Abnormal VLDL$398,886
R01 · FY2004 · HL
Distinct Human Macrophage Receptor for Abnormal VLDL$387,268
R01 · FY2003 · HL
DISTINCT HUMAN MACROPHAGE RECEPTOR FOR ABNORMAL VLDL$433,343
R01 · FY2002 · HL
ATHEROGENICITY OF POSTPRANDIAL TRIGLYCRIDE-RICH LIPOPROTEINS (PPTGRLP)$0
M01 · FY2002 · RR
DISTINCT HUMAN MACROPHAGE RECEPTOR FOR ABNORMAL VLDL$420,720
R01 · FY2001 · HL
ATHEROGENICITY OF POSTPRANDIAL TRIGLYCRIDE-RICH LIPOPROTEINS (PPTGRLP)$0
M01 · FY2001 · RR
DISTINCT HUMAN MACROPHAGE RECEPTOR FOR ABNORMAL VLDL$408,466
R01 · FY2000 · HL
ATHEROGENICITY OF POSTPRANDIAL TRIGLYCRIDE-RICH LIPOPROTEINS (PPTGRLP)$29,529
M01 · FY2000 · RR